Brevan Howard Capital Management LP Kura Oncology, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 47,690 shares of KURA stock, worth $534,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,690
Previous 13,929
242.38%
Holding current value
$534,128
Previous $80,000
427.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
212Shares Held
81.3MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...